Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO)

TWD 27.9

(-0.18%)

EBITDA Summary of Chi Sheng Pharma & Biotech Co., Ltd

  • Chi Sheng Pharma & Biotech Co., Ltd's latest annual EBITDA in 2023 was 117.55 Million TWD , down -50.33% from previous year.
  • Chi Sheng Pharma & Biotech Co., Ltd's latest quarterly EBITDA in 2024 Q1 was 45.43 Million TWD , up 48.55% from previous quarter.
  • Chi Sheng Pharma & Biotech Co., Ltd reported an annual EBITDA of 225.2 Million TWD in 2022, up 11.67% from previous year.
  • Chi Sheng Pharma & Biotech Co., Ltd reported an annual EBITDA of 197.48 Million TWD in 2021, up 27.88% from previous year.
  • Chi Sheng Pharma & Biotech Co., Ltd reported a quarterly EBITDA of 42.62 Million TWD for 2024 Q2, down -6.21% from previous quarter.
  • Chi Sheng Pharma & Biotech Co., Ltd reported a quarterly EBITDA of 30.37 Million TWD for 2023 Q4, down -27.94% from previous quarter.

Annual EBITDA Chart of Chi Sheng Pharma & Biotech Co., Ltd (2023 - 2019)

Historical Annual EBITDA of Chi Sheng Pharma & Biotech Co., Ltd (2023 - 2019)

Year EBITDA EBITDA Growth
2023 117.55 Million TWD -50.33%
2022 225.2 Million TWD 11.67%
2021 197.48 Million TWD 27.88%
2020 164.58 Million TWD -7.92%
2019 178.91 Million TWD 0.0%

Peer EBITDA Comparison of Chi Sheng Pharma & Biotech Co., Ltd

Name EBITDA EBITDA Difference
St.Shine Optical Co.,Ltd. 1.01 Billion TWD 88.373%
Bioteque Corporation 736.13 Million TWD 84.031%
Sunder Biomedical Tech. Co., Ltd. 76.61 Million TWD -53.436%
BenQ Medical Technology Corporation 532.15 Million TWD 77.91%
Pacific Hospital Supply Co., Ltd 673.8 Million TWD 82.554%
Unicon Optical Co., Ltd. 377.24 Million TWD 68.84%
Formosa Optical Technology Co.,Ltd. 1.04 Billion TWD 88.756%
Medeon Biodesign, Inc. -1.14 Billion TWD 110.294%
Concord Medical Co., Ltd. 137.47 Million TWD 14.491%
Crystalvue Medical Corporation 149.73 Million TWD 21.491%
Perfect Medical Industry Co., Ltd. 115.48 Million TWD -1.794%
ICARES Medicus, Inc. 165.54 Million TWD 28.989%
Lagis Enterprise Co., Ltd. 112.36 Million TWD -4.617%
Amed Co., Ltd. 157.32 Million TWD 25.281%